Employers classified under the Professional, Scientific, and Technical Services industry based in Massachusetts submitted 6,451 H-1B petitions during 2024, according to data provided by the U.S. Citizenship and Immigration Services via the H-1B Employer Data Hub.
Of these, 6,298 were approved (97.6%), while 153 were denied (2.4%).
Employers are classified under industries based on their reported operations and may be involved in multiple industries.
The H-1B visa program allows U.S. employers to temporarily hire foreign workers in specialty occupations requiring specialized knowledge and at least a bachelor’s degree or equivalent. It is designed to address skill gaps in the U.S. workforce while ensuring wage standards to protect both U.S. and H-1B workers. Employers must certify that they will pay H-1B workers wages equal to or greater than those of similarly qualified U.S. employees or the prevailing local wage.
The average approval rate for H-1B petitions across the United States in 2024 stood at 98%, higher than 2023’s 97.3%. Statewide, Massachusetts employers across all industries submitted 16,232 petitions during the same period, achieving an approval rate of 97.8%.
The Professional, Scientific, and Technical Services industry led the H-1B filings in Massachusetts during 2024, with 6,451 petitions (39.7% of all submissions), and an approval rate of 97.6%. Meanwhile, the Finance and Insurance industry was the second largest contributor, filing 2,928 petitions (18% of the total), with an approval rate of 98.8%.
The Massachusetts employers which made the most petitions in the Professional, Scientific, and Technical Services sector during 2024 included Virtusa Corporation with 531 petitions, Randstad Digital, LLC with 396 petitions, and The Boston Consulting Group, Inc. with 387 petitions.
Compared to 2023, the Professional, Scientific, and Technical Services sector in Massachusetts saw a 0.2% decrease in the number of H-1B petitions during 2024.
The United States admits around 1 million legal immigrants annually, most of whom receive permanent residence (green cards) through family sponsorship or employment-based visas. In 2023, about 1.2 million immigrants were granted green cards, a return to pre-pandemic levels. Temporary visa programs, such as the H-1B for highly skilled workers and H-2A for seasonal agricultural workers, also play a critical role in filling workforce needs.
Public opinion on immigration varies, with 46% of Americans favoring maintaining current legal immigration levels, according to a 2024 Pew Research Center survey. Additionally, 42% believe that highly skilled workers, such as scientists, doctors, and programmers, should be prioritized for legal immigration, compared to 25% who prioritize workers filling labor shortages and 19% who emphasize family sponsorship. Despite this, family sponsorship remains the most common path to permanent residency, accounting for 63% of green cards issued in 2023.
The data in this article comes from the H-1B Employer Data Hub provided by the U.S. Citizenship and Immigration Services (USCIS). While USCIS strives for accuracy, manual data entry and errors on paper forms submitted by applicants or petitioners may result in discrepancies in employer names, tax IDs, locations, or other details.
H-1B Petitions by Industry in Massachusetts, 2024
| Rank | Industry | Total Petitions | % of All Submissions | % Approved | % Denied |
|---|---|---|---|---|---|
| 1 | Professional, Scientific, and Technical Services | 6,451 | 39.7% | 97.6% | 2.4% |
| 2 | Finance and Insurance | 2,928 | 18% | 98.8% | 1.2% |
| 3 | Health Care and Social Assistance | 1,738 | 10.7% | 95.9% | 4.1% |
| 4 | Manufacturing | 1,585 | 9.8% | 99.1% | 1% |
| 5 | Educational Services | 1,199 | 7.4% | 98.5% | 1.5% |
| 6 | Information | 1,071 | 6.6% | 97.3% | 2.7% |
| 7 | Retail Trade | 420 | 2.6% | 97.9% | 2.1% |
| 8 | Administrative and Support and Waste Management and Remediation Services | 229 | 1.4% | 97.4% | 2.6% |
| 9 | Public Administration | 98 | 0.6% | 98% | 2% |
| 10 | Utilities | 91 | 0.6% | 96.7% | 3.3% |
| 11 | Other Services (except Public Administration) | 88 | 0.5% | 94.3% | 5.7% |
| 12 | Construction | 86 | 0.5% | 96.5% | 3.5% |
| 13 | Wholesale Trade | 70 | 0.4% | 98.6% | 1.4% |
| 14 | Arts, Entertainment, and Recreation | 45 | 0.3% | 97.8% | 2.2% |
| 14 | Real Estate and Rental and Leasing | 45 | 0.3% | 93.3% | 6.7% |
| 16 | Transportation and Warehousing | 32 | 0.2% | 90.6% | 9.4% |
| 17 | Accommodation and Food Services | 27 | 0.2% | 85.2% | 14.8% |
| 18 | Management of Companies and Enterprises | 22 | 0.1% | 100% | 0% |
| 19 | Mining, Quarrying, and Oil and Gas Extraction | 4 | 0% | 100% | 0% |
| 20 | Agriculture, Forestry, Fishing and Hunting | 3 | 0% | 100% | 0% |
Top Employers in Professional, Scientific, and Technical Services Industry in Massachusetts, 2024
| Rank | Company Name | Total Petitions | % Approved | % Denied |
|---|---|---|---|---|
| 1 | Virtusa Corporation | 531 | 97.9% | 2.1% |
| 2 | Randstad Digital, LLC | 396 | 98.2% | 1.8% |
| 3 | The Boston Consulting Group, Inc. | 387 | 99% | 1% |
| 4 | Randstad Technologies, LLC | 146 | 86.3% | 13.7% |
| 5 | Avco Consulting, Inc. | 129 | 93.8% | 6.2% |
| 6 | Collaborate Solutions, Inc. | 111 | 93.7% | 6.3% |
| 7 | Bain and Company, Inc. | 107 | 98.1% | 1.9% |
| 8 | Thermo Fisher Scientific, Inc. | 105 | 98.1% | 1.9% |
| 9 | Dana-Farber Cancer Institute | 103 | 99% | 1% |
| 10 | Vertex Pharmaceuticals Incorporate | 95 | 100% | 0% |
| 11 | Modernatx, Inc. | 93 | 97.9% | 2.2% |
| 12 | Eclinicalworks, LLC | 85 | 100% | 0% |
| 13 | Sapient Corporation | 83 | 97.6% | 2.4% |
| 14 | Athenahealth, Inc. | 81 | 100% | 0% |
| 15 | Analysis Group, Inc. | 80 | 98.8% | 1.3% |
| 16 | Bahwan Cybertek, Inc. | 76 | 100% | 0% |
| 17 | Ventois, Inc. | 72 | 97.2% | 2.8% |
| 18 | Dassault Systemes Americas, Corp. | 65 | 98.5% | 1.5% |
| 19 | Motional Ad, Inc. | 57 | 96.5% | 3.5% |
| 19 | Solution It, Inc. | 57 | 96.5% | 3.5% |
| 21 | APPS Associates, LLC | 52 | 96.2% | 3.9% |
| 22 | Quantiphi, Inc. | 51 | 94.1% | 5.9% |
| 23 | Broad Institute | 50 | 100% | 0% |
| 24 | Cornerstone Research, Inc. | 39 | 97.4% | 2.6% |
| 24 | BCT Consulting, Inc. | 39 | 100% | 0% |
| 26 | CRA International, Inc. | 35 | 100% | 0% |
| 27 | Parexel International, LLC | 34 | 94.1% | 5.9% |
| 27 | Netscout Systems, Inc. | 34 | 100% | 0% |
| 29 | Intersystems Corporation | 33 | 100% | 0% |
| 30 | EMD Millipore Corporation | 30 | 100% | 0% |
| 30 | Charles River Laboratories, Inc. | 30 | 100% | 0% |
| 30 | Ginkgo Bioworks, Inc. | 30 | 100% | 0% |
| 30 | Source Consulting, LLC | 30 | 96.7% | 3.3% |
| 34 | Vertex Pharmaceuticals Incorporated | 28 | 96.4% | 3.6% |
| 35 | Healthedge Software, Inc. | 27 | 100% | 0% |
| 35 | Cytel, Inc. | 27 | 100% | 0% |
| 37 | Cloud Bridge Solutions, Inc. | 26 | 100% | 0% |
| 37 | Trinity Partners, LLC | 26 | 100% | 0% |
| 39 | Quality Matrix, Inc. | 25 | 100% | 0% |
| 39 | Moderna Services, Inc. | 25 | 100% | 0% |
| 39 | Dotcom Team, LLC | 25 | 96% | 4% |
| 42 | Intellia Therapeutics, Inc. | 24 | 100% | 0% |
| 42 | Genzyme Corporation | 24 | 100% | 0% |
| 44 | The Brattle Group, Inc. | 23 | 95.7% | 4.4% |
| 44 | Goodwin Procter, LLP | 23 | 100% | 0% |
| 46 | Cognex Corporation | 22 | 100% | 0% |
| 47 | Berkshire Grey, Inc. | 21 | 100% | 0% |
| 47 | Pegasystems, Inc. | 21 | 100% | 0% |
| 47 | Iconsoft, Inc. | 21 | 100% | 0% |
| 47 | Beigene USA, Inc. | 21 | 100% | 0% |
| 47 | Dana Farber Cancer Institute | 21 | 100% | 0% |
| 52 | Duck Creek Technologies, LLC | 20 | 100% | 0% |
| 52 | Lek Consulting, LLC | 20 | 100% | 0% |
| 54 | Tripadvisor, LLC | 19 | 100% | 0% |
| 54 | Irobot Corporation | 19 | 100% | 0% |
| 54 | Aspentech Corporation | 19 | 100% | 0% |
| 57 | Biontech US, Inc. | 18 | 100% | 0% |
| 57 | Toast, Inc. | 18 | 100% | 0% |
| 57 | Crispr Therapeutics, Inc. | 18 | 94.4% | 5.6% |
| 57 | CDM Smith, Inc. | 18 | 100% | 0% |
| 61 | Clearview Healthcare Partners, LLC | 17 | 100% | 0% |
| 61 | UKG, Inc. | 17 | 100% | 0% |
| 61 | Ropes and Gray, LLP | 17 | 100% | 0% |
| 61 | Pathai, Inc. | 17 | 100% | 0% |
| 65 | Nycasoft, Inc. | 16 | 100% | 0% |
| 65 | Tracelink, Inc. | 16 | 93.8% | 6.3% |
| 65 | Sasaki Associates | 16 | 100% | 0% |
| 65 | Editas Medicine, Inc. | 16 | 93.8% | 6.3% |
| 65 | Wavesoft Solutions, Inc. | 16 | 81.3% | 18.8% |
| 70 | Tessera Therapeutics, Inc. | 15 | 100% | 0% |
| 70 | Abridge Info Systems, Inc. | 15 | 86.7% | 13.3% |
| 70 | Clean Harbors Environmental Servic | 15 | 100% | 0% |
| 70 | LLX Solutions, LLC | 15 | 100% | 0% |
| 70 | Sigma-Aldrich Corporation | 15 | 100% | 0% |
| 75 | DPS Group, Inc. | 14 | 92.9% | 7.1% |
| 75 | Webject Systems, Inc. | 14 | 100% | 0% |
| 75 | The BSST Software Group | 14 | 92.9% | 7.1% |
| 75 | Westernacher and Partner Consultin | 14 | 100% | 0% |
| 75 | Technician Dynamix It Services | 14 | 100% | 0% |
| 80 | Stellix Global Services, Inc. | 13 | 84.6% | 15.4% |
| 80 | Beam Therapeutics, Inc. | 13 | 100% | 0% |
| 80 | Bain & Company, Inc. | 13 | 100% | 0% |
| 83 | Akra Solutions, LLC | 12 | 100% | 0% |
| 83 | Revenue Solutions, Inc. | 12 | 100% | 0% |
| 83 | Forrester Research, Inc. | 12 | 100% | 0% |
| 83 | Vestmark, Inc. | 12 | 100% | 0% |
| 87 | Wave Life Sciences USA, Inc. | 11 | 100% | 0% |
| 87 | Woods Hole Oceanographic Instituti | 11 | 100% | 0% |
| 87 | Wasabi Technologies, LLC | 11 | 100% | 0% |
| 87 | Galaxy US Opco D B a Vialto PA, Inc. | 11 | 100% | 0% |
| 87 | Zensoft It Solutions, Inc. | 11 | 90.9% | 9.1% |
| 87 | Sumitomo Pharma America, Inc. | 11 | 90.9% | 9.1% |
| 87 | M&R Consultants Corporation | 11 | 90.9% | 9.1% |
| 87 | Ebsco Publishing D B a Ebsco Infor | 11 | 100% | 0% |
| 87 | TRI Ventures D B a Aquent LLC, Inc. | 11 | 100% | 0% |
| 96 | Global Life Sciences Solutions USA | 10 | 100% | 0% |
| 96 | Blueprint Medicines Corporation | 10 | 100% | 0% |
| 96 | Gei Consultants, Inc. | 10 | 100% | 0% |
| 96 | Payette Associates, Inc. | 10 | 100% | 0% |
| 96 | Ebsco Publishing | 10 | 100% | 0% |
| 96 | Aorton, Inc. | 10 | 100% | 0% |
| 96 | Idol Soft, Inc. | 10 | 100% | 0% |
| 96 | Peopleserve, Inc. | 10 | 100% | 0% |
| 96 | Cambridge Systematics, Inc. | 10 | 100% | 0% |
| 105 | Netbrain Technologies, Inc. | 9 | 88.9% | 11.1% |
| 105 | Simpson Gumpertz and Heger, Inc. | 9 | 100% | 0% |
| 105 | UKG Kronos Systems, LLC | 9 | 100% | 0% |
| 105 | Whitehead Institute for Biomedical | 9 | 100% | 0% |
| 105 | Simon Kucher and Partners Strategy | 9 | 100% | 0% |
| 105 | Digitas, Inc. | 9 | 100% | 0% |
| 105 | Prime Software Technologies, Inc. | 9 | 88.9% | 11.1% |
| 105 | Dassault Systemes Solidworks Corpo | 9 | 100% | 0% |
| 105 | Mobi Systems, Inc. | 9 | 100% | 0% |
| 114 | Tuv Sud America, Inc. | 8 | 100% | 0% |
| 114 | Elevatebio Technologies, Inc. | 8 | 100% | 0% |
| 114 | Navisite | 8 | 100% | 0% |
| 114 | Authright, Inc. | 8 | 100% | 0% |
| 114 | Boston Data Pro, LLC | 8 | 87.5% | 12.5% |
| 114 | Biocytogen Boston, Corp. | 8 | 100% | 0% |
| 114 | Wilmer Cutler Pickering Hale and Dorr, LLP | 8 | 100% | 0% |
| 114 | Weston & Sampson Engineers, Inc. | 8 | 87.5% | 12.5% |
| 114 | Techmorgonite Software Solutions, LLC | 8 | 75% | 25% |
| 114 | Foley Hoag, LLP | 8 | 100% | 0% |
| 114 | Sage Therapeutics, Inc. | 8 | 100% | 0% |
| 114 | Prime Medicine, Inc. | 8 | 100% | 0% |
| 114 | Boston Dynamics, Inc. | 8 | 100% | 0% |
| 127 | Mass Design Group, Ltd. | 7 | 85.7% | 14.3% |
| 127 | Softworld, LLC | 7 | 100% | 0% |
| 127 | Logan Data, Inc. | 7 | 100% | 0% |
| 127 | Arvin Acme Technologies, Inc. | 7 | 100% | 0% |
| 127 | Inari Agriculture, Inc. | 7 | 100% | 0% |
| 127 | Bluebird Bio, Inc. | 7 | 100% | 0% |
| 127 | Bitsight Technologies, Inc. | 7 | 100% | 0% |
| 127 | Neoxam Americas, Inc. | 7 | 100% | 0% |
| 127 | Commonwealth Fusion HR, LLC | 7 | 100% | 0% |
| 127 | Primeon, Inc. | 7 | 100% | 0% |
| 127 | Soltex Systems, LLC | 7 | 100% | 0% |
| 127 | New England It Associates, Inc. | 7 | 100% | 0% |
| 127 | Yzenx, Inc. | 7 | 100% | 0% |
| 127 | Idnor Technologies, Inc. | 7 | 100% | 0% |
| 127 | Generate Biomedicines, Inc. | 7 | 100% | 0% |
| 127 | Verve Therapeutics, Inc. | 7 | 100% | 0% |
| 143 | Inbiz Concepts, Inc. | 6 | 83.3% | 16.7% |
| 143 | Venisa, Inc. | 6 | 100% | 0% |
| 143 | Resourcesoft, Inc. | 6 | 83.3% | 16.7% |
| 143 | Avride F K a Yandex Self Driving Group Inc., Inc. | 6 | 100% | 0% |
| 143 | Imprivata, Inc. | 6 | 100% | 0% |
| 143 | National Bureau of Economic Research, Inc. | 6 | 100% | 0% |
| 143 | Simpson Gumpertz & Heger, Inc. | 6 | 100% | 0% |
| 143 | Public Consulting Group, LLC | 6 | 100% | 0% |
| 143 | Neuraflash | 6 | 100% | 0% |
| 143 | Replimune, Inc. | 6 | 100% | 0% |
| 143 | The Dennis Group, Inc. | 6 | 100% | 0% |
| 143 | Dyne Therapeutics, Inc. | 6 | 100% | 0% |
| 143 | Quantumid Technologies, Inc. | 6 | 100% | 0% |
| 143 | Haley and Aldrich, Inc. | 6 | 100% | 0% |
| 143 | Arcadia Solutions, LLC | 6 | 100% | 0% |
| 143 | Cbt-Childs Bertman Tseckares, Inc. | 6 | 100% | 0% |
| 143 | Systemonex, Inc. | 6 | 83.3% | 16.7% |
| 143 | Applause APP Quality, Inc. | 6 | 100% | 0% |
| 143 | Bioreliance Corporation | 6 | 100% | 0% |
| 143 | Cervello, Inc. | 6 | 100% | 0% |
| 163 | I-Services, Inc. | 5 | 100% | 0% |
| 163 | Advisor360, LLC | 5 | 100% | 0% |
| 163 | Tome Biosciences, Inc. | 5 | 100% | 0% |
| 163 | Voyager Therapeutics, Inc. | 5 | 100% | 0% |
| 163 | Evolutionary Systems, Corp. | 5 | 100% | 0% |
| 163 | Boston Dynamics Ai Institute, LLC | 5 | 100% | 0% |
| 163 | Contrive Solutions, Inc. | 5 | 100% | 0% |
| 163 | Intellia Therapeutics | 5 | 80% | 20% |
| 163 | Hiq Technologies, LLC | 5 | 100% | 0% |
| 163 | Trigent Software, Inc. | 5 | 100% | 0% |
| 163 | Progress Software Corporation | 5 | 100% | 0% |
| 163 | Aeternus Solutions, Inc. | 5 | 100% | 0% |
| 163 | Tamr, Inc. | 5 | 100% | 0% |
| 163 | Sail Biomedicines, Inc. | 5 | 100% | 0% |
| 163 | Progress Software | 5 | 100% | 0% |
| 163 | Overjet, Inc. | 5 | 80% | 20% |
| 163 | Talentburst, Inc. | 5 | 100% | 0% |
| 163 | Goto Technologies USA, Inc. | 5 | 100% | 0% |
| 163 | Everbridge, Inc. | 5 | 100% | 0% |
| 163 | Ilogic Tek, LLC | 5 | 100% | 0% |
| 163 | Adroit Software, Inc. | 5 | 100% | 0% |
| 163 | Smithsonian Institution | 5 | 100% | 0% |
| 163 | L E K Consulting, LLC | 5 | 100% | 0% |
| 163 | Solidenergy Systems, LLC | 5 | 100% | 0% |
| 163 | Green International Affiliates, Inc. | 5 | 100% | 0% |
| 163 | Altman Solon US LP | 5 | 100% | 0% |
| 163 | Definitive Healthcare, LLC | 5 | 100% | 0% |
| 190 | Treeline Biosciences, Inc. | 4 | 100% | 0% |
| 190 | Forsyth Institute | 4 | 100% | 0% |
| 190 | Justice Resource Institute, Inc. | 4 | 100% | 0% |
| 190 | Relay Therapeutics, Inc. | 4 | 100% | 0% |
| 190 | Zettabyte, LLC | 4 | 100% | 0% |
| 190 | Spear Bio, Inc. | 4 | 75% | 25% |
| 190 | Isee, Inc. | 4 | 100% | 0% |
| 190 | Superace D B a Superace Media, LLC | 4 | 100% | 0% |
| 190 | Gray Decision Intelligence, Inc. | 4 | 100% | 0% |
| 190 | Akoya Biosciences, Inc. | 4 | 100% | 0% |
| 190 | Rapid7, LLC | 4 | 100% | 0% |
| 190 | Tuv Rheinland of North America, Inc. | 4 | 100% | 0% |
| 190 | Nextbits, Inc. | 4 | 100% | 0% |
| 190 | Crosscheck Networks, Inc. | 4 | 100% | 0% |
| 190 | Auxo Solutions, LLC | 4 | 100% | 0% |
| 190 | Harbinger Health, Inc. | 4 | 100% | 0% |
| 190 | IDC Research, Inc. | 4 | 100% | 0% |
| 190 | Vor Biopharma, Inc. | 4 | 100% | 0% |
| 190 | Deep Health, Inc. | 4 | 100% | 0% |
| 190 | Be Biopharma, Inc. | 4 | 100% | 0% |
| 190 | Anaqua, Inc. | 4 | 75% | 25% |
| 190 | Rizing Consulting USA, Inc. | 4 | 75% | 25% |
| 190 | Aadva, LLC | 4 | 100% | 0% |
| 190 | Volta Labs, Inc. | 4 | 100% | 0% |
| 190 | Lemessurier Consultants, Inc. | 4 | 100% | 0% |
| 190 | Everquote, Inc. | 4 | 100% | 0% |
| 190 | Yarewin, LLC | 4 | 100% | 0% |
| 190 | Daymark Energy Advisors, Inc. | 4 | 100% | 0% |
| 190 | Snapdragon Chemistry, Inc. | 4 | 100% | 0% |
| 190 | Enel X Storage, LLC | 4 | 75% | 25% |
| 190 | Utile, Inc. | 4 | 100% | 0% |
| 190 | Qiagen Beverly, LLC | 4 | 100% | 0% |
| 190 | Williamsmarston, LLC | 4 | 100% | 0% |
| 190 | Entrada Therapeutics, Inc. | 4 | 100% | 0% |
| 190 | Constant Contact, Inc. | 4 | 75% | 25% |
| 190 | Uptycs, Inc. | 4 | 100% | 0% |
| 190 | Doble Engineering Company | 4 | 100% | 0% |
| 190 | Elkus Manfredi Architects, Ltd. | 4 | 100% | 0% |
| 190 | Fog Pharmaceuticals, Inc. | 4 | 100% | 0% |
| 190 | MT Law, LLC | 4 | 100% | 0% |
| 190 | Strategic Solutions Group, LLC | 4 | 100% | 0% |
| 190 | DW Matrix, Inc. | 4 | 100% | 0% |
| 190 | Lotusworks, Inc. | 4 | 100% | 0% |
| 190 | Flagship Labs 85, Inc. | 4 | 100% | 0% |
| 190 | Isgenuity, LLC | 4 | 100% | 0% |
| 190 | Revvity Signals Software, Inc. | 4 | 100% | 0% |
| 190 | Tscan Therapeutics, Inc. | 4 | 100% | 0% |
| 237 | Dermbiont, Inc. | 3 | 100% | 0% |
| 237 | 24M Technologies, Inc. | 3 | 100% | 0% |
| 237 | Vanasse Hangen Brustlin, Inc. | 3 | 100% | 0% |
| 237 | Flexcompute, Inc. | 3 | 100% | 0% |
| 237 | Pihu, LLC | 3 | 100% | 0% |
| 237 | Baim Institute for Clinical Research | 3 | 100% | 0% |
| 237 | Lions Law, PC | 3 | 100% | 0% |
| 237 | Auxo Streams, LLC | 3 | 100% | 0% |
| 237 | Edge Environment Sustainability Company | 3 | 100% | 0% |
| 237 | Institute for Protein Innovation I | 3 | 100% | 0% |
| 237 | Mitsubishi Electric Research Labor | 3 | 100% | 0% |
| 237 | PA Consulting Group, Inc. | 3 | 100% | 0% |
| 237 | Enanta Pharmaceuticals, Inc. | 3 | 100% | 0% |
| 237 | Modulate, Inc. | 3 | 100% | 0% |
| 237 | Putnam Associates, LLC | 3 | 100% | 0% |
| 237 | Cerevel Therapeutics D B a Cer, LLC | 3 | 100% | 0% |
| 237 | Landmark Bio PBLLC | 3 | 66.7% | 33.3% |
| 237 | Saliogen Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Parallel Squared Technology Institute, LLC | 3 | 100% | 0% |
| 237 | Mikyoung Kim Design, LLC | 3 | 100% | 0% |
| 237 | Department Digital Products, Inc. | 3 | 100% | 0% |
| 237 | BL Healthcare, Inc. | 3 | 100% | 0% |
| 237 | Chroma Medicine, Inc. | 3 | 100% | 0% |
| 237 | Pieriandx, Inc. | 3 | 100% | 0% |
| 237 | Visterra, Inc. | 3 | 100% | 0% |
| 237 | Groupeconnect, LLC | 3 | 100% | 0% |
| 237 | Baim Institute for Clinical Resear | 3 | 100% | 0% |
| 237 | Candel Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Bluesnap, Inc. | 3 | 100% | 0% |
| 237 | Cellarity, Inc. | 3 | 100% | 0% |
| 237 | CJ Biomaterials, Inc. | 3 | 100% | 0% |
| 237 | Myeloid Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Alloy Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Simcere of America, Inc. | 3 | 100% | 0% |
| 237 | Bizanalytica, LLC | 3 | 66.7% | 33.3% |
| 237 | Pi Health USA, LLC | 3 | 100% | 0% |
| 237 | Eze Castle Integration, Inc. | 3 | 100% | 0% |
| 237 | Reed Hilderbrand, LLC | 3 | 100% | 0% |
| 237 | Marine Biological Laboratory | 3 | 100% | 0% |
| 237 | Vedanta Biosciences, Inc. | 3 | 100% | 0% |
| 237 | Mintz Levin Cohn Ferris Glovsky an | 3 | 100% | 0% |
| 237 | Avride F K a Yandex Self Drivi, Inc. | 3 | 66.7% | 33.3% |
| 237 | Veristat, LLC | 3 | 100% | 0% |
| 237 | Michael Van Valkenburgh Associates, Inc. | 3 | 100% | 0% |
| 237 | Assure Eservices, Inc. | 3 | 100% | 0% |
| 237 | Montai Health, Inc. | 3 | 100% | 0% |
| 237 | Arena Bioworks, LLC | 3 | 100% | 0% |
| 237 | Ring Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Vayu Global Health Foundation, Inc. | 3 | 100% | 0% |
| 237 | JL Consulting Incorporated | 3 | 100% | 0% |
| 237 | Mersana Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Triverus Consulting, LLC | 3 | 100% | 0% |
| 237 | Perez Gardini, LLC | 3 | 100% | 0% |
| 237 | Insycom, Inc. | 3 | 100% | 0% |
| 237 | Northway Biotech, Inc. | 3 | 100% | 0% |
| 237 | Genewiz, LLC | 3 | 100% | 0% |
| 237 | Labcorp Endpoint Clinical, Inc. | 3 | 100% | 0% |
| 237 | Embarc, Inc. | 3 | 100% | 0% |
| 237 | Kronos Incorporated | 3 | 100% | 0% |
| 237 | Thrive Software Technologies, LLC | 3 | 66.7% | 33.3% |
| 237 | GZA Geoenvironmental, Inc. | 3 | 100% | 0% |
| 237 | Cardiofocus, Inc. | 3 | 100% | 0% |
| 237 | Applied Value Technologies, Inc. | 3 | 100% | 0% |
| 237 | Goody Clancy and Associates, Inc. | 3 | 100% | 0% |
| 237 | Abclonal Science, Inc. | 3 | 100% | 0% |
| 237 | Oneglobe, LLC | 3 | 100% | 0% |
| 237 | Pepgen, Inc. | 3 | 100% | 0% |
| 237 | Agent Mednet, Inc. | 3 | 100% | 0% |
| 237 | It Force, Inc. | 3 | 100% | 0% |
| 237 | Intepros Incorporated | 3 | 100% | 0% |
| 237 | Azenta, Inc. | 3 | 100% | 0% |
| 237 | Lifemine Therapeutics, Inc. | 3 | 100% | 0% |
| 237 | Securebio, Inc. | 3 | 100% | 0% |
| 237 | Chaossearch, Inc. | 3 | 100% | 0% |
| 237 | Teknobit Solutions, Inc. | 3 | 66.7% | 33.3% |
| 237 | Induspad International, Inc. | 3 | 100% | 0% |
| 237 | Figur8, Inc. | 3 | 100% | 0% |
| 237 | Soroco Americas Private Limited | 3 | 100% | 0% |
| 237 | Arranta Bio MA, LLC | 3 | 100% | 0% |
| 237 | Woodwell Climate Research Center I | 3 | 100% | 0% |
| 237 | Prometrika, LLC | 3 | 100% | 0% |
| 237 | One Door | 3 | 100% | 0% |
| 237 | Aligned Incentives, LLC | 3 | 100% | 0% |
| 237 | Veracode, Inc. | 3 | 100% | 0% |
| 237 | Harvard University – Harvard Pilgr | 3 | 100% | 0% |
| 237 | Endpoint Clinical, Inc. | 3 | 100% | 0% |
| 237 | Clarion Healthcare, LLC | 3 | 100% | 0% |
| 237 | Kyruus, Inc. | 3 | 66.7% | 33.3% |
| 237 | Onprocess Technology, Inc. | 3 | 100% | 0% |
| 326 | Yurogen Biosystems, LLC | 2 | 100% | 0% |
| 326 | Salsify, Inc. | 2 | 100% | 0% |
| 326 | Health Data Analytics Institute in | 2 | 100% | 0% |
| 326 | Cbiz Accounting Tax & Advisory of New England, LLC | 2 | 100% | 0% |
| 326 | Ensoma, Inc. | 2 | 100% | 0% |
| 326 | Navisite, LLC | 2 | 100% | 0% |
| 326 | Black Math, Inc. | 2 | 100% | 0% |
| 326 | Quantco, Inc. | 2 | 100% | 0% |
| 326 | System Custom Consultants, LLC | 2 | 100% | 0% |
| 326 | Stoss, Inc. | 2 | 100% | 0% |
| 326 | Appian Way Energy Partners, LLC | 2 | 100% | 0% |
| 326 | The Architectural Team, Inc. | 2 | 100% | 0% |
| 326 | Abacus Insights, Inc. | 2 | 100% | 0% |
| 326 | Safety Partners, LLC | 2 | 100% | 0% |
| 326 | Affini-T Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | First Line Software, Inc. | 2 | 100% | 0% |
| 326 | Mystudio, LLC | 2 | 100% | 0% |
| 326 | Xformics, Inc. | 2 | 100% | 0% |
| 326 | BPG Bio, Inc. | 2 | 100% | 0% |
| 326 | Kymera Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Whitehead Institute for Biomedical Research | 2 | 100% | 0% |
| 326 | AVS Soft Solutions, Inc. | 2 | 100% | 0% |
| 326 | Seceon, Inc. | 2 | 100% | 0% |
| 326 | Allshore Technologies, LLC | 2 | 100% | 0% |
| 326 | Atacama Biomaterials, Inc. | 2 | 100% | 0% |
| 326 | Bullhorn, Inc. | 2 | 100% | 0% |
| 326 | Nvelop Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Health Advances, LLC | 2 | 100% | 0% |
| 326 | Beacon Interactive Systems, LLC | 2 | 100% | 0% |
| 326 | Engene USA, Inc. | 2 | 100% | 0% |
| 326 | Simcere Zaiming, Inc. | 2 | 100% | 0% |
| 326 | Pristine Infotech, Inc. | 2 | 100% | 0% |
| 326 | Emerald Innovations, Inc. | 2 | 100% | 0% |
| 326 | Congruent Solutions, Inc. | 2 | 100% | 0% |
| 326 | Boston International Media Consult | 2 | 100% | 0% |
| 326 | Dragonfly Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Apogee Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Bargmann Hendrie Archetype, Inc. | 2 | 100% | 0% |
| 326 | Cartera Commerce, Inc. | 2 | 100% | 0% |
| 326 | Oxford Biomedica US, LLC | 2 | 100% | 0% |
| 326 | Emulate, Inc. | 2 | 100% | 0% |
| 326 | Metaphore Biotechnologies, Inc. | 2 | 100% | 0% |
| 326 | Ironwood Pharmaceuticals, Inc. | 2 | 100% | 0% |
| 326 | Tango Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Xellar, Inc. | 2 | 100% | 0% |
| 326 | Botkeeper, Inc. | 2 | 100% | 0% |
| 326 | Nitsch Engineering, Inc. | 2 | 100% | 0% |
| 326 | Safdie Architects, LLC | 2 | 100% | 0% |
| 326 | Apriori Bio, Inc. | 2 | 100% | 0% |
| 326 | Curis, Inc. | 2 | 100% | 0% |
| 326 | New Ecology, Inc. | 2 | 100% | 0% |
| 326 | Dimella Shaffer Associates, Inc. | 2 | 100% | 0% |
| 326 | Onezero Financial Systems, LLC | 2 | 100% | 0% |
| 326 | Elevatebio Base Camp, Inc. | 2 | 100% | 0% |
| 326 | Biofourmis, Inc. | 2 | 100% | 0% |
| 326 | Maxima Consulting, Inc. | 2 | 50% | 50% |
| 326 | Pharmaessentia Innovation Research Center, Inc. | 2 | 100% | 0% |
| 326 | Nuclera Nucleics Corporation | 2 | 100% | 0% |
| 326 | 3share, Inc. | 2 | 100% | 0% |
| 326 | Dyno Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Mabuhay Enterprises, Inc. | 2 | 100% | 0% |
| 326 | Energy Services Group, LLC | 2 | 100% | 0% |
| 326 | Medadvisor Welam USA, Inc. | 2 | 100% | 0% |
| 326 | Interpro Solutions, LLC | 2 | 100% | 0% |
| 326 | Confiance Technician Solutions, Inc. | 2 | 100% | 0% |
| 326 | Arisglobal, LLC | 2 | 100% | 0% |
| 326 | Boston Institute of Biotechnology, LLC | 2 | 100% | 0% |
| 326 | The Vertex Companies, LLC | 2 | 100% | 0% |
| 326 | Camp4 Therapeutics Corporation | 2 | 100% | 0% |
| 326 | Bluerock Therapeutics LP | 2 | 100% | 0% |
| 326 | Tessellati, LLC | 2 | 100% | 0% |
| 326 | Odyssey Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Stellix Group, Inc. | 2 | 0% | 100% |
| 326 | Bard Rao & Athanas Consulting Engineers, LLC | 2 | 100% | 0% |
| 326 | Cargometrics Technologies, Inc. | 2 | 100% | 0% |
| 326 | Shepley Bulfinch Richardson and Ab | 2 | 100% | 0% |
| 326 | Emugen Therapeutics, LLC | 2 | 100% | 0% |
| 326 | City Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Am Batteries, Inc. | 2 | 100% | 0% |
| 326 | Integrated Computer Solutions, Inc. | 2 | 100% | 0% |
| 326 | Repertoire Immune Medicines, Inc. | 2 | 100% | 0% |
| 326 | SDL, Inc. | 2 | 100% | 0% |
| 326 | Elemental Machines, Inc. | 2 | 100% | 0% |
| 326 | Hifibio, Inc. | 2 | 100% | 0% |
| 326 | TRN Digital, LLC | 2 | 100% | 0% |
| 326 | Allen and Gerritsen, Inc. | 2 | 100% | 0% |
| 326 | Performance Architects, Inc. | 2 | 100% | 0% |
| 326 | Broadmoor Solutions, Inc. | 2 | 100% | 0% |
| 326 | Hayes Management Consulting, LLC | 2 | 100% | 0% |
| 326 | Agenus, Inc. | 2 | 100% | 0% |
| 326 | Prismhr, Inc. | 2 | 100% | 0% |
| 326 | Flagship Labs 97, Inc. | 2 | 100% | 0% |
| 326 | Iterative Scopes, Inc. | 2 | 100% | 0% |
| 326 | Nanite, Inc. | 2 | 100% | 0% |
| 326 | Photonwares Corporation | 2 | 100% | 0% |
| 326 | Galatea Associates, LLC | 2 | 100% | 0% |
| 326 | Embark Veterinary, Inc. | 2 | 100% | 0% |
| 326 | Terva Corporation | 2 | 100% | 0% |
| 326 | Odysseus Data Services, Inc. | 2 | 100% | 0% |
| 326 | Simon-Kucher & Partners Strategy & Marketing Consultants, LLC | 2 | 50% | 50% |
| 326 | Aerodyne Research, Inc. | 2 | 50% | 50% |
| 326 | Empyrean Solutions, LLC | 2 | 100% | 0% |
| 326 | UII America, Inc. | 2 | 100% | 0% |
| 326 | Filtered, Inc. | 2 | 100% | 0% |
| 326 | Voisin Consulting, Inc. | 2 | 50% | 50% |
| 326 | Wyebot, Inc. | 2 | 100% | 0% |
| 326 | Neupole Technologies, LLC | 2 | 100% | 0% |
| 326 | Oneshield, Inc. | 2 | 100% | 0% |
| 326 | Scpharmaceuticals, Inc. | 2 | 100% | 0% |
| 326 | Elektrofi, Inc. | 2 | 100% | 0% |
| 326 | Dynamicure Biotechnology, LLC | 2 | 100% | 0% |
| 326 | Sahasait, Inc. | 2 | 50% | 50% |
| 326 | Lusha USA Operation, Inc. | 2 | 100% | 0% |
| 326 | Agency Landscape & Planning, LLC | 2 | 50% | 50% |
| 326 | Flagship Labs 94, Inc. | 2 | 100% | 0% |
| 326 | Xtalpi, Inc. | 2 | 100% | 0% |
| 326 | Charles Hudson Technology Solutions, Inc. | 2 | 100% | 0% |
| 326 | Meadowhawk Biolabs, Inc. | 2 | 100% | 0% |
| 326 | Symmes Maini & Mckee Associates, Inc. | 2 | 100% | 0% |
| 326 | RI-2, LLC | 2 | 100% | 0% |
| 326 | Rediker Software, Inc. | 2 | 50% | 50% |
| 326 | Giner, Inc. | 2 | 100% | 0% |
| 326 | Zaether, Corp. | 2 | 100% | 0% |
| 326 | Lase Innovation, Inc. | 2 | 100% | 0% |
| 326 | A2Z Radiology Ai, Inc. | 2 | 100% | 0% |
| 326 | Healthcare Financial, Inc. | 2 | 100% | 0% |
| 326 | Marathonsoft, LLC | 2 | 100% | 0% |
| 326 | Codametrix, Inc. | 2 | 100% | 0% |
| 326 | Mindq, Inc. | 2 | 100% | 0% |
| 326 | Osprey Software, Inc. | 2 | 100% | 0% |
| 326 | Empress Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Icon Architecture, Inc. | 2 | 100% | 0% |
| 326 | Typhoon Hil, Inc. | 2 | 100% | 0% |
| 326 | Sosolimited, LLC | 2 | 50% | 50% |
| 326 | Mural Oncology, Inc. | 2 | 100% | 0% |
| 326 | Garuda Therapuetics, Inc. | 2 | 100% | 0% |
| 326 | Arrowstreet, Inc. | 2 | 100% | 0% |
| 326 | Wukong Media, LLC | 2 | 100% | 0% |
| 326 | Strobus Infosoft, LLC | 2 | 100% | 0% |
| 326 | Karen Clark and Company | 2 | 100% | 0% |
| 326 | Cultivarium, LLC | 2 | 100% | 0% |
| 326 | Cambridge Consultants, Inc. | 2 | 100% | 0% |
| 326 | Schumacher Company, Inc. | 2 | 100% | 0% |
| 326 | Egenesis, Inc. | 2 | 100% | 0% |
| 326 | Trivedi Advanced Technologies, LLC | 2 | 100% | 0% |
| 326 | Instylla, Inc. | 2 | 100% | 0% |
| 326 | Mobile Heartbeat, LLC | 2 | 100% | 0% |
| 326 | Analog Photonics, LLC | 2 | 100% | 0% |
| 326 | Generation Bio Company | 2 | 100% | 0% |
| 326 | Q-Square Business Intelligence, Corp. | 2 | 100% | 0% |
| 326 | Sustainable Energy Advantage, LLC | 2 | 100% | 0% |
| 326 | Sustainable Minds, LLC | 2 | 100% | 0% |
| 326 | The Predictive Index D B a the, LLC | 2 | 100% | 0% |
| 326 | HMFH Architects, Inc. | 2 | 100% | 0% |
| 326 | Mcnamara-Salvia, Inc. | 2 | 100% | 0% |
| 326 | Realtime Robotics, Inc. | 2 | 100% | 0% |
| 326 | Akston Biosciences Corporation | 2 | 100% | 0% |
| 326 | Pillar Biosciences, Inc. | 2 | 100% | 0% |
| 326 | Vizgen, Inc. | 2 | 100% | 0% |
| 326 | Boston Technology Corporation | 2 | 100% | 0% |
| 326 | Ropes & Gray, LLP | 2 | 100% | 0% |
| 326 | Gupta Media Holdings, LLC | 2 | 100% | 0% |
| 326 | Four Colors Technology, LLC | 2 | 100% | 0% |
| 326 | Reliance Engineers, LLC | 2 | 100% | 0% |
| 326 | Zoomrx, Inc. | 2 | 100% | 0% |
| 326 | Abcellera Boston, Inc. | 2 | 100% | 0% |
| 326 | Massachusetts Medical Society | 2 | 100% | 0% |
| 326 | Etechnology Services, LLC | 2 | 100% | 0% |
| 326 | Smartleaf, Inc. | 2 | 100% | 0% |
| 326 | Affinia Therapeutics | 2 | 100% | 0% |
| 326 | Sigma-Aldrich Company, LLC | 2 | 100% | 0% |
| 326 | United Supply Chain, Inc. | 2 | 100% | 0% |
| 326 | Spectrosys Solutions, Inc. | 2 | 100% | 0% |
| 326 | Converge Consulting, LLC | 2 | 100% | 0% |
| 326 | Tcognition, Inc. | 2 | 100% | 0% |
| 326 | Ascidian Therapeutics, Inc. | 2 | 100% | 0% |
| 326 | Xperttech, Inc. | 2 | 50% | 50% |
| 326 | Q32 Bio, Inc. | 2 | 100% | 0% |
| 504 | Geocomp Corporation | 1 | 100% | 0% |
| 504 | Teknicloud, Inc. | 1 | 100% | 0% |
| 504 | Bummock Ai, Inc. | 1 | 100% | 0% |
| 504 | Landwise, LLC | 1 | 100% | 0% |
| 504 | Easygo Warehouse Services Corporation | 1 | 100% | 0% |
| 504 | Treeful Damaso Aniceto, Inc. | 1 | 100% | 0% |
| 504 | Beacon Technician D B a Marigold Hea, Inc. | 1 | 100% | 0% |
| 504 | Magnet Biomedicine, Inc. | 1 | 100% | 0% |
| 504 | Simcorp Coric, Inc. | 1 | 100% | 0% |
| 504 | Indigo Agent, Inc. | 1 | 100% | 0% |
| 504 | Clutec, Inc. | 1 | 100% | 0% |
| 504 | Miller Wachman, LLP | 1 | 100% | 0% |
| 504 | PRM Solutions, Inc. | 1 | 100% | 0% |
| 504 | Start2 Group, Inc. | 1 | 100% | 0% |
| 504 | Anodyne Nanotech, Inc. | 1 | 100% | 0% |
| 504 | JD Software, Inc. | 1 | 100% | 0% |
| 504 | Corra Technology, Inc. | 1 | 100% | 0% |
| 504 | Ray Dunetz Landscape Architecture, Inc. | 1 | 100% | 0% |
| 504 | Servier Bio-Innovation, LLC | 1 | 100% | 0% |
| 504 | Emind Technology, Inc. | 1 | 0% | 100% |
| 504 | Cic Labs, Inc. | 1 | 100% | 0% |
| 504 | Megalodon Management, Inc. | 1 | 100% | 0% |
| 504 | Fennick Mccredie Architecture, Ltd. | 1 | 100% | 0% |
| 504 | Sophia Genetics | 1 | 100% | 0% |
| 504 | Iovis Technologies, LLC | 1 | 100% | 0% |
| 504 | Vivonics, Inc. | 1 | 100% | 0% |
| 504 | MP Design Consultants, LLC | 1 | 100% | 0% |
| 504 | Consolidated Marketing Services, Inc. | 1 | 100% | 0% |
| 504 | Gamble Associates, LLC | 1 | 100% | 0% |
| 504 | Arnold Worldwide, LLC | 1 | 100% | 0% |
| 504 | Woods Hole Oceanographic Institution | 1 | 100% | 0% |
| 504 | Boston Lighthouse Innovations, Inc. | 1 | 100% | 0% |
| 504 | Komodo Technologies, LLC | 1 | 100% | 0% |
| 504 | Nextdroid, Inc. | 1 | 100% | 0% |
| 504 | Dream Collaborative, LLC | 1 | 100% | 0% |
| 504 | Rome Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Think-Cell, Inc. | 1 | 100% | 0% |
| 504 | GTC Law Group, PC | 1 | 100% | 0% |
| 504 | Capesym, Inc. | 1 | 100% | 0% |
| 504 | Orphan Drugs Cloud Foundation Company | 1 | 0% | 100% |
| 504 | Weiss Consulting | 1 | 100% | 0% |
| 504 | Board Americas, Inc. | 1 | 100% | 0% |
| 504 | CRR, LLP | 1 | 100% | 0% |
| 504 | Dicerna Pharmaceuticals, Inc. | 1 | 100% | 0% |
| 504 | Global QMS, Inc. | 1 | 100% | 0% |
| 504 | Available Light, Inc. | 1 | 100% | 0% |
| 504 | Cadmus Holding Company, Inc. | 1 | 100% | 0% |
| 504 | Leap Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Olix US, Inc. | 1 | 100% | 0% |
| 504 | Onboard Partners, LLC | 1 | 100% | 0% |
| 504 | Schneider Electric Smart Grid Solutions, LLC | 1 | 100% | 0% |
| 504 | Hello Coupon, Inc. | 1 | 100% | 0% |
| 504 | Alignable, Inc. | 1 | 100% | 0% |
| 504 | Cellens, Inc. | 1 | 100% | 0% |
| 504 | Eta Wireless, Inc. | 1 | 100% | 0% |
| 504 | Skylla Technologies, Inc. | 1 | 100% | 0% |
| 504 | Coherence Healthcare, Inc. | 1 | 100% | 0% |
| 504 | Proleit, Corp. | 1 | 100% | 0% |
| 504 | Harte Hanks Direct, Inc. | 1 | 100% | 0% |
| 504 | Bastionzero, Inc. | 1 | 100% | 0% |
| 504 | London Economics International, LLC | 1 | 100% | 0% |
| 504 | Cartera Commerce a Rakuten Company, Inc. | 1 | 100% | 0% |
| 504 | Siena Engineering Group, Inc. | 1 | 100% | 0% |
| 504 | Idex America, Inc. | 1 | 100% | 0% |
| 504 | Ultivue, Inc. | 1 | 100% | 0% |
| 504 | Clade Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Metrika, Inc. | 1 | 100% | 0% |
| 504 | Precidiag, Inc. | 1 | 100% | 0% |
| 504 | Amy Cai CPA, Inc. | 1 | 100% | 0% |
| 504 | Controlpoint Techs, Inc. | 1 | 100% | 0% |
| 504 | Quintara Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Deepcure, Inc. | 1 | 100% | 0% |
| 504 | General Metabolics, LLC | 1 | 100% | 0% |
| 504 | Tausight, Inc. | 1 | 100% | 0% |
| 504 | Aryan Consulting, Inc. | 1 | 100% | 0% |
| 504 | David J Prothero CPA, PC | 1 | 100% | 0% |
| 504 | Noble Supply and Logistics, LLC | 1 | 100% | 0% |
| 504 | DVX Atomic Company | 1 | 100% | 0% |
| 504 | Companyon, LLC | 1 | 100% | 0% |
| 504 | Full Spectrum Software, LLC | 1 | 100% | 0% |
| 504 | Aquinnah Pharmaceuticals, Inc. | 1 | 100% | 0% |
| 504 | Keydata Associates, LLC | 1 | 100% | 0% |
| 504 | Cvision Ai, Inc. | 1 | 100% | 0% |
| 504 | New England Biolabs, Inc. | 1 | 100% | 0% |
| 504 | Disc Medicine, Inc. | 1 | 100% | 0% |
| 504 | Graphisoft North America, Inc. | 1 | 100% | 0% |
| 504 | The Laboratory Safety Institute | 1 | 0% | 100% |
| 504 | Cambridge Isotope Laboratories, Inc. | 1 | 0% | 100% |
| 504 | Liepin North America, Inc. | 1 | 100% | 0% |
| 504 | Ace Up, Inc. | 1 | 100% | 0% |
| 504 | Only Orphans Cote, LLC | 1 | 100% | 0% |
| 504 | HKT Architects, Inc. | 1 | 100% | 0% |
| 504 | Trupti N Patel and Associates | 1 | 100% | 0% |
| 504 | Maxview Solutions, Inc. | 1 | 100% | 0% |
| 504 | Pharmaron Boston Lab Services, LLC | 1 | 100% | 0% |
| 504 | Tectonic Therapeutic, Inc. | 1 | 100% | 0% |
| 504 | Ysat Solutions, LLC | 1 | 100% | 0% |
| 504 | 4G Clinical, LLC | 1 | 100% | 0% |
| 504 | E11 Bio, LLC | 1 | 100% | 0% |
| 504 | TRC Engineers, LLC | 1 | 0% | 100% |
| 504 | Machado and Silvetti Associates, Inc. | 1 | 100% | 0% |
| 504 | Cavanaugh Tocci Associates, Inc. | 1 | 100% | 0% |
| 504 | Valo Health, Inc. | 1 | 100% | 0% |
| 504 | Spryte Medical, Inc. | 1 | 100% | 0% |
| 504 | Flaskworks, LLC | 1 | 100% | 0% |
| 504 | Anmahian Winton Associates, Inc. | 1 | 100% | 0% |
| 504 | Jayva US, Inc. | 1 | 100% | 0% |
| 504 | Watershed Informatics, Inc. | 1 | 100% | 0% |
| 504 | I-Kanda Architects | 1 | 100% | 0% |
| 504 | Medullar Solutions, Inc. | 1 | 100% | 0% |
| 504 | Fenergo, Inc. | 1 | 100% | 0% |
| 504 | Soni Technologies, LLC | 1 | 100% | 0% |
| 504 | Virtusoft, Inc. | 1 | 100% | 0% |
| 504 | Movensys Corporation | 1 | 100% | 0% |
| 504 | Galy Company | 1 | 100% | 0% |
| 504 | Syros Pharmaceuticals, Inc. | 1 | 100% | 0% |
| 504 | Armenian Cultural Association of America, Inc. | 1 | 100% | 0% |
| 504 | Kojin Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Dasksoft, Inc. | 1 | 100% | 0% |
| 504 | Robert W. Sullivan, Inc. | 1 | 100% | 0% |
| 504 | Lionbridge Technologies, LLC | 1 | 100% | 0% |
| 504 | Advanced Technology Innovation Corporation | 1 | 100% | 0% |
| 504 | Orna Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Seres Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Jura Bio, Inc. | 1 | 100% | 0% |
| 504 | Wecover Platforms, Inc. | 1 | 100% | 0% |
| 504 | Nested Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Regal Voice, Inc. | 1 | 0% | 100% |
| 504 | Diamond Tofu, LLC | 1 | 100% | 0% |
| 504 | C&K Component, LLC | 1 | 100% | 0% |
| 504 | Leanix, Inc. | 1 | 100% | 0% |
| 504 | Zero Asic Corporation | 1 | 100% | 0% |
| 504 | Oho Corporation | 1 | 100% | 0% |
| 504 | Aafcpas, Inc. | 1 | 100% | 0% |
| 504 | Edge Animal Health, Inc. | 1 | 100% | 0% |
| 504 | Schneider Electric Smart Grid Solu | 1 | 100% | 0% |
| 504 | Hebecell, Corp. | 1 | 100% | 0% |
| 504 | Bergmeyer Associates, Inc. | 1 | 100% | 0% |
| 504 | Alegeus Technologies, LLC | 1 | 100% | 0% |
| 504 | Marveri, Inc. | 1 | 100% | 0% |
| 504 | Peakpoint Technologies, Inc. | 1 | 100% | 0% |
| 504 | ERP Center for Excellence, Inc. | 1 | 100% | 0% |
| 504 | Institute for Future Intelligence, Inc. | 1 | 100% | 0% |
| 504 | Cognitive Scientific Ai, Inc. | 1 | 100% | 0% |
| 504 | Mintz Levin Cohn Ferris Glovsky and Popeo, P C | 1 | 100% | 0% |
| 504 | Project Evident, Inc. | 1 | 100% | 0% |
| 504 | Stoke Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Affectiva, Inc. | 1 | 100% | 0% |
| 504 | Sherlock Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Polus Solutions Formerly Genes, Inc. | 1 | 100% | 0% |
| 504 | Precede Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Fireblocks, Inc. | 1 | 100% | 0% |
| 504 | Spagnolo Gisness and Associates in | 1 | 100% | 0% |
| 504 | Ampersand Biomedicines, Inc. | 1 | 100% | 0% |
| 504 | Quilt Ai, LLC | 1 | 100% | 0% |
| 504 | Kula Bio, Inc. | 1 | 100% | 0% |
| 504 | David a Levy CPA, LLC | 1 | 100% | 0% |
| 504 | Dumontjanks, LLC | 1 | 100% | 0% |
| 504 | Comniscient Technologies, LLC | 1 | 100% | 0% |
| 504 | Public Partnerships, LLC | 1 | 100% | 0% |
| 504 | Suno, Inc. | 1 | 100% | 0% |
| 504 | Fulcrum Research Group, LLC | 1 | 100% | 0% |
| 504 | Keros Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Boston Data Science, LLC | 1 | 100% | 0% |
| 504 | Gradco D B a Gradient, LLC | 1 | 100% | 0% |
| 504 | The Institute for Healthcare Optim | 1 | 100% | 0% |
| 504 | Cambridge Immigration Law, PC | 1 | 100% | 0% |
| 504 | Leyton USA, Inc. | 1 | 100% | 0% |
| 504 | Acceleration Partners, LLC | 1 | 100% | 0% |
| 504 | Seaport Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Truleague Incorporated | 1 | 100% | 0% |
| 504 | Ceres, Inc. | 1 | 100% | 0% |
| 504 | Evidence for Healthcare Improvement, Inc. | 1 | 100% | 0% |
| 504 | Softpak Financial Systems, Inc. | 1 | 100% | 0% |
| 504 | Astadia, Inc. | 1 | 100% | 0% |
| 504 | Yet2.com, Inc. | 1 | 100% | 0% |
| 504 | Brunercott and Associates, Inc. | 1 | 100% | 0% |
| 504 | Lambert Shortell & Connaughton, LLC | 1 | 100% | 0% |
| 504 | Salient Predictions, Inc. | 1 | 100% | 0% |
| 504 | Transcera, Inc. | 1 | 100% | 0% |
| 504 | HC Bioscience, Inc. | 1 | 100% | 0% |
| 504 | Airna Corporation | 1 | 100% | 0% |
| 504 | Causely, Inc. | 1 | 100% | 0% |
| 504 | Parallel Fluidics, Inc. | 1 | 100% | 0% |
| 504 | Validation Consulting Group, LLC | 1 | 100% | 0% |
| 504 | Microbial Machines, Inc. | 1 | 100% | 0% |
| 504 | Pristine Engineers, Inc. | 1 | 100% | 0% |
| 504 | Spinnaker, LLC | 1 | 100% | 0% |
| 504 | Flagship Labs 99, Inc. | 1 | 100% | 0% |
| 504 | J2 Interactive, LLC | 1 | 100% | 0% |
| 504 | Cornerstone Energy Services, Inc. | 1 | 100% | 0% |
| 504 | Deon Policy Institute | 1 | 100% | 0% |
| 504 | Gentibio, Inc. | 1 | 100% | 0% |
| 504 | Techno Bytes, Inc. | 1 | 100% | 0% |
| 504 | Hydro-Environmental Technologies I | 1 | 100% | 0% |
| 504 | Tutor Intelligence, Inc. | 1 | 100% | 0% |
| 504 | China Med Device, LLC | 1 | 100% | 0% |
| 504 | Sonata Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Qsoft Systems, Inc. | 1 | 100% | 0% |
| 504 | Syntricate Technologies, Inc. | 1 | 100% | 0% |
| 504 | Wizardpig, Inc. | 1 | 100% | 0% |
| 504 | Kognitiv, Inc. | 1 | 100% | 0% |
| 504 | Darmody Merlino and Company, LLP | 1 | 100% | 0% |
| 504 | Next Phase Studios, Inc. | 1 | 100% | 0% |
| 504 | Greensight, Inc. | 1 | 100% | 0% |
| 504 | Bai Technologies, Inc. | 1 | 100% | 0% |
| 504 | Linnean Solutions, LLC | 1 | 100% | 0% |
| 504 | Advanced Technology Innovation Cor | 1 | 100% | 0% |
| 504 | Orca DB, Inc. | 1 | 100% | 0% |
| 504 | Sense Labs, Inc. | 1 | 100% | 0% |
| 504 | Apellis Pharmaceuticals, Inc. | 1 | 100% | 0% |
| 504 | Joseph F Fournier JR AIA D B a JFF | 1 | 100% | 0% |
| 504 | Nereid Therapeutics Incorporated | 1 | 100% | 0% |
| 504 | Diagonal Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Global Competitiveness D B a, Corp. | 1 | 100% | 0% |
| 504 | Zageno, Inc. | 1 | 100% | 0% |
| 504 | C4 Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Leal Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Satellite Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Healthfleet, Inc. | 1 | 100% | 0% |
| 504 | Bella Research Group, LLC | 1 | 100% | 0% |
| 504 | Alantra Technician USA, LLC | 1 | 100% | 0% |
| 504 | Cell Signaling Technology, Inc. | 1 | 100% | 0% |
| 504 | Epicore Biosystems, Inc. | 1 | 100% | 0% |
| 504 | Innovative Process Solutions, Inc. | 1 | 100% | 0% |
| 504 | Forge Team, Inc. | 1 | 100% | 0% |
| 504 | Hammer Technologies, Inc. | 1 | 100% | 0% |
| 504 | Locus, Inc. | 1 | 100% | 0% |
| 504 | Oxford Biomedica Solutions, LLC | 1 | 100% | 0% |
| 504 | Metalor Technologies USA Corporation | 1 | 100% | 0% |
| 504 | Pointr USA Limited | 1 | 100% | 0% |
| 504 | Finite Accounting and Tax, Inc. | 1 | 100% | 0% |
| 504 | Spacerake, Inc. | 1 | 100% | 0% |
| 504 | Iron Mountain Information Management, LLC | 1 | 100% | 0% |
| 504 | Contracts 365, Inc. | 1 | 100% | 0% |
| 504 | Mustang Bio, Inc. | 1 | 0% | 100% |
| 504 | Quelltx, Inc. | 1 | 100% | 0% |
| 504 | Deep Genomics Delaware, Inc. | 1 | 100% | 0% |
| 504 | Ge Vernova International, LLC | 1 | 100% | 0% |
| 504 | Arvato USA, LLC | 1 | 100% | 0% |
| 504 | X-Chem, Inc. | 1 | 100% | 0% |
| 504 | Bothwell Engineering, Inc. | 1 | 100% | 0% |
| 504 | Kudo Biotechnology, Inc. | 1 | 0% | 100% |
| 504 | Datarobot, Inc. | 1 | 100% | 0% |
| 504 | Nira Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Duckbill, Inc. | 1 | 100% | 0% |
| 504 | Safc, Inc. | 1 | 100% | 0% |
| 504 | Ting Management Group, Corp. | 1 | 100% | 0% |
| 504 | Commure, Inc. | 1 | 100% | 0% |
| 504 | Frontera Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Appsys Global, Inc. | 1 | 100% | 0% |
| 504 | Kernal Biologics, Inc. | 1 | 100% | 0% |
| 504 | Whele HR, LLC | 1 | 100% | 0% |
| 504 | Curii Corporation F K a Curoverse | 1 | 100% | 0% |
| 504 | Dimagi, Inc. | 1 | 100% | 0% |
| 504 | GPR, Inc. | 1 | 100% | 0% |
| 504 | Cambridge Energy Solutions, LLC | 1 | 100% | 0% |
| 504 | Oneview Commerce, Inc. | 1 | 100% | 0% |
| 504 | Centime, Inc. | 1 | 100% | 0% |
| 504 | Mavenoid, Inc. | 1 | 100% | 0% |
| 504 | Snyk, Ltd. | 1 | 100% | 0% |
| 504 | Lam Partners, Inc. | 1 | 100% | 0% |
| 504 | Nova Ai, Inc. | 1 | 100% | 0% |
| 504 | 1uphealth, Inc. | 1 | 100% | 0% |
| 504 | Be Biopharma | 1 | 100% | 0% |
| 504 | Catamaran Bio, Inc. | 1 | 100% | 0% |
| 504 | Panorama Consulting and Engineering, Inc. | 1 | 100% | 0% |
| 504 | Energy Management, Inc. | 1 | 100% | 0% |
| 504 | Sigma-Aldrich RTC, Inc. | 1 | 100% | 0% |
| 504 | Imotions, Inc. | 1 | 100% | 0% |
| 504 | Vacovec, Mayotte & Singer, LLP | 1 | 100% | 0% |
| 504 | Cleartelligence Holdings, LLC | 1 | 100% | 0% |
| 504 | Spiky Ai, Inc. | 1 | 100% | 0% |
| 504 | Warner Larson, Inc. | 1 | 100% | 0% |
| 504 | Corevitas, LLC | 1 | 100% | 0% |
| 504 | Dennis Colwell Architects, Inc. | 1 | 100% | 0% |
| 504 | Genezen MA, Inc. | 1 | 100% | 0% |
| 504 | Technical Development Corporation | 1 | 100% | 0% |
| 504 | Medacuity, LLC | 1 | 100% | 0% |
| 504 | Extreme Reach, Inc. | 1 | 100% | 0% |
| 504 | Videahealth, Inc. | 1 | 100% | 0% |
| 504 | Interpretable Ai, LLC | 1 | 100% | 0% |
| 504 | Concepta Software Solutions, LLC | 1 | 100% | 0% |
| 504 | QLD Biotherapeutics, Inc. | 1 | 100% | 0% |
| 504 | Synthpop, Inc. | 1 | 100% | 0% |
| 504 | Kisbee Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Boston Industrial Consulting, Inc. | 1 | 100% | 0% |
| 504 | Kiwi Technologies D B a Guardi, Inc. | 1 | 100% | 0% |
| 504 | Newton Energy Group, LLC | 1 | 100% | 0% |
| 504 | The Verndale Corporation | 1 | 100% | 0% |
| 504 | Greenough Communications Group, Inc. | 1 | 100% | 0% |
| 504 | Camp Profiles, LLC | 1 | 100% | 0% |
| 504 | Lin Associates, Inc. | 1 | 100% | 0% |
| 504 | Advanced RNA Technologies, LLC | 1 | 100% | 0% |
| 504 | Optirtc, Inc. | 1 | 100% | 0% |
| 504 | Seismic Therapeutic, Inc. | 1 | 100% | 0% |
| 504 | Horsley Witten Group, Inc. | 1 | 100% | 0% |
| 504 | Tulip Interfaces, Inc. | 1 | 100% | 0% |
| 504 | Creativestar Solutions, Inc. | 1 | 100% | 0% |
| 504 | Redliker Software, Inc. | 1 | 100% | 0% |
| 504 | Dewpoint Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Aurus, Inc. | 1 | 100% | 0% |
| 504 | Zag Bio, Inc. | 1 | 100% | 0% |
| 504 | Bynder, LLC | 1 | 100% | 0% |
| 504 | LDA Architecture & Interiors, LLP | 1 | 100% | 0% |
| 504 | A. I. S., Inc. | 1 | 100% | 0% |
| 504 | Trial and Error, Inc. | 1 | 100% | 0% |
| 504 | AL Proteins, Inc. | 1 | 100% | 0% |
| 504 | Celedon Law, PC | 1 | 100% | 0% |
| 504 | Mariana Oncology, Inc. | 1 | 100% | 0% |
| 504 | Paul Lukez Architecture | 1 | 100% | 0% |
| 504 | Entrepreneurship for All, Inc. | 1 | 100% | 0% |
| 504 | Innes Associates, Ltd. | 1 | 100% | 0% |
| 504 | Cogent Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Mink Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Folia Materials, Inc. | 1 | 0% | 100% |
| 504 | We Create Goodness, LLC | 1 | 100% | 0% |
| 504 | Care Everywhere, LLC | 1 | 100% | 0% |
| 504 | Shepherd Therapeutics, LLC | 1 | 0% | 100% |
| 504 | Iconics, Inc. | 1 | 100% | 0% |
| 504 | Bloomer Health Technician | 1 | 100% | 0% |
| 504 | Circle Internet Financial, LLC | 1 | 100% | 0% |
| 504 | PM Group USA, Inc. | 1 | 100% | 0% |
| 504 | Alvaria, Inc. | 1 | 100% | 0% |
| 504 | Constellation Pharmaceuticals, Inc. | 1 | 100% | 0% |
| 504 | Murata Power Solutions, Inc. | 1 | 100% | 0% |
| 504 | GC Theraputics, Inc. | 1 | 100% | 0% |
| 504 | Artlog, Inc. | 1 | 100% | 0% |
| 504 | Boston-Softdesign, Inc. | 1 | 100% | 0% |
| 504 | KSQ Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Data Verity Corporation | 1 | 100% | 0% |
| 504 | Nimbus Therapeutics, LLC | 1 | 100% | 0% |
| 504 | RSE Associates, Inc. | 1 | 100% | 0% |
| 504 | Tines Automation, Inc. | 1 | 100% | 0% |
| 504 | Bamboo Rose, LLC | 1 | 100% | 0% |
| 504 | Care Access Research, LLC | 1 | 100% | 0% |
| 504 | LNS Global D B a LNS Research, Inc. | 1 | 100% | 0% |
| 504 | Mobile Messaging Solutions, Inc. | 1 | 100% | 0% |
| 504 | Protobrand Sciences, Inc. | 1 | 100% | 0% |
| 504 | Sullivan and Worcester, LLP | 1 | 100% | 0% |
| 504 | Freightplus, Inc. | 1 | 100% | 0% |
| 504 | Keenee, Corp. | 1 | 100% | 0% |
| 504 | Boston Analytics Group, LLC | 1 | 100% | 0% |
| 504 | Curadev Pharma, Inc. | 1 | 100% | 0% |
| 504 | Repare Therapeutics USA, Inc. | 1 | 100% | 0% |
| 504 | Digtinctive, LLC | 1 | 0% | 100% |
| 504 | Cambridge Crops D/B/S Mori, Inc. | 1 | 100% | 0% |
| 504 | Zus Health, Inc. | 1 | 100% | 0% |
| 504 | Abio-X Holdings, Inc. | 1 | 100% | 0% |
| 504 | HI Marley, Inc. | 1 | 100% | 0% |
| 504 | Bigtime Software, Inc. | 1 | 100% | 0% |
| 504 | Allen & Gerritsen, Inc. | 1 | 100% | 0% |
| 504 | Centessa Pharmaceuticals, LLC | 1 | 100% | 0% |
| 504 | Matterworks, Inc. | 1 | 100% | 0% |
| 504 | Verdant Landscape Architecture, Inc. | 1 | 100% | 0% |
| 504 | 1up Health, Inc. | 1 | 100% | 0% |
| 504 | Traackr, Inc. | 1 | 100% | 0% |
| 504 | Hayes & O’Neill, LLC | 1 | 100% | 0% |
| 504 | Catalant Technologies, Inc. | 1 | 100% | 0% |
| 504 | Panorama Consulting and Engineerin | 1 | 100% | 0% |
| 504 | Sigma-Aldrich Manufacturing, LLC | 1 | 100% | 0% |
| 504 | Sigma-Aldrich Research Biochemical | 1 | 100% | 0% |
| 504 | Michael Blier Landworks, Inc. | 1 | 100% | 0% |
| 504 | SPI Research Development Services | 1 | 100% | 0% |
| 504 | Analogic Corporation | 1 | 100% | 0% |
| 504 | Itas Consulting, LLC | 1 | 100% | 0% |
| 504 | Waltech, Inc. | 1 | 100% | 0% |
| 504 | Coralogix, Inc. | 1 | 100% | 0% |
| 504 | Nabla Bio, Inc. | 1 | 100% | 0% |
| 504 | Raina Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Denneen and Company, Inc. | 1 | 100% | 0% |
| 504 | Phosphorex, LLC | 1 | 0% | 100% |
| 504 | Exosome Diagnostics, Inc. | 1 | 100% | 0% |
| 504 | Via Separations, Inc. | 1 | 100% | 0% |
| 504 | Intermolecular, Inc. | 1 | 100% | 0% |
| 504 | Monotype Imaging, Inc. | 1 | 100% | 0% |
| 504 | Conagen, Inc. | 1 | 100% | 0% |
| 504 | Gaia Ai, Inc. | 1 | 100% | 0% |
| 504 | Arealtek, Inc. | 1 | 100% | 0% |
| 504 | Khani Staffing Technician, Corp. | 1 | 100% | 0% |
| 504 | Boston Identity, LLC | 1 | 100% | 0% |
| 504 | New England Wheels, Inc. | 1 | 100% | 0% |
| 504 | Dolead, Inc. | 1 | 100% | 0% |
| 504 | The Space Consortium | 1 | 100% | 0% |
| 504 | Greenlight Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Ba, Inc. | 1 | 100% | 0% |
| 504 | Cameron Micheroni Silvia, LLC | 1 | 100% | 0% |
| 504 | Lightelligence, Inc. | 1 | 100% | 0% |
| 504 | Openspring USA, LLC | 1 | 100% | 0% |
| 504 | Security Innovation, Inc. | 1 | 100% | 0% |
| 504 | Homerun Technology Corporation | 1 | 100% | 0% |
| 504 | Tufin Software North America, Inc. | 1 | 100% | 0% |
| 504 | Biosurfaces, Inc. | 1 | 100% | 0% |
| 504 | Neosome Life Sciences, LLC | 1 | 100% | 0% |
| 504 | Despark, Inc. | 1 | 100% | 0% |
| 504 | Tensixty Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Aura Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Business Value Intelligence Service in | 1 | 100% | 0% |
| 504 | Obsidian Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Beigene US Manufacturing Company, Inc. | 1 | 100% | 0% |
| 504 | Aktis Oncology, Inc. | 1 | 100% | 0% |
| 504 | Marcus Gleysteen Architects, LLC | 1 | 100% | 0% |
| 504 | Patrick Ahearn Architect, LLC | 1 | 100% | 0% |
| 504 | Vaxess Technologies, Inc. | 1 | 100% | 0% |
| 504 | Inndura Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Professional Alternative, Inc. | 1 | 0% | 100% |
| 504 | Stellaromics, Inc. | 1 | 100% | 0% |
| 504 | Anthology Biotechnologies, Inc. | 1 | 100% | 0% |
| 504 | Jesson Oslin and Associates, LLP | 1 | 0% | 100% |
| 504 | Wayanalytics, LLC | 1 | 100% | 0% |
| 504 | Aera Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Shah Dixit Associates, PC | 1 | 100% | 0% |
| 504 | Bloom Architecture, Inc. | 1 | 100% | 0% |
| 504 | Circe Bioscience, Inc. | 1 | 100% | 0% |
| 504 | Merge Architects, Inc. | 1 | 100% | 0% |
| 504 | Pledge Biosciences D B a Pledg, LLC | 1 | 100% | 0% |
| 504 | Filter Labs, Inc. | 1 | 100% | 0% |
| 504 | Alvamed, Inc. | 1 | 100% | 0% |
| 504 | Ipromoteu.com, Inc. | 1 | 100% | 0% |
| 504 | VNC, LLC | 1 | 100% | 0% |
| 504 | Tabors Caramanis Rudkevich, Inc. | 1 | 100% | 0% |
| 504 | Boston Venture Studio, Inc. | 1 | 100% | 0% |
| 504 | Dassault Systemes Solidworks Corporation | 1 | 100% | 0% |
| 504 | Nift Networks, Inc. | 1 | 100% | 0% |
| 504 | Drylab, Inc. | 1 | 100% | 0% |
| 504 | Committee on Capital Markets Regul | 1 | 100% | 0% |
| 504 | Proteinea, Inc. | 1 | 100% | 0% |
| 504 | Fractyl Health, Inc. | 1 | 100% | 0% |
| 504 | Boslan Engineering, Ltd. | 1 | 100% | 0% |
| 504 | Network Coverage, LLC | 1 | 100% | 0% |
| 504 | Reliance Solutions, Inc. | 1 | 0% | 100% |
| 504 | Avant-Garde Solutions, Ltd. | 1 | 100% | 0% |
| 504 | Leers Weinzapfel Associates Archit | 1 | 100% | 0% |
| 504 | Zsfab, Inc. | 1 | 100% | 0% |
| 504 | Hevolution Foundation US | 1 | 100% | 0% |
| 504 | Bigr Dot Io, LLC | 1 | 100% | 0% |
| 504 | Alira Health Boston, LLC | 1 | 100% | 0% |
| 504 | Center for Coastal Studies, Inc. | 1 | 100% | 0% |
| 504 | Mathearth, Inc. | 1 | 100% | 0% |
| 504 | Eustace Consulting, Inc. | 1 | 100% | 0% |
| 504 | Verastem, Inc. | 1 | 100% | 0% |
| 504 | Columbia Construction Company | 1 | 100% | 0% |
| 504 | Dynamic Ideas, LLC | 1 | 100% | 0% |
| 504 | Tonneson and Company, PC | 1 | 100% | 0% |
| 504 | Hayden Consulting Group, LLC | 1 | 100% | 0% |
| 504 | BBK Worldwide, LLC | 1 | 100% | 0% |
| 504 | LSC Lifesciences Consultants Brook | 1 | 100% | 0% |
| 504 | Casner & Edwards, LLP | 1 | 100% | 0% |
| 504 | Panalgo | 1 | 100% | 0% |
| 504 | Enel X Advisory Services USA, LLC | 1 | 100% | 0% |
| 504 | Clark and Elbing, LLP | 1 | 100% | 0% |
| 504 | Michael Blier / Landworks, Inc. | 1 | 100% | 0% |
| 504 | Spectrus, LLC | 1 | 100% | 0% |
| 504 | Flagship Labs 87, Inc. | 1 | 100% | 0% |
| 504 | Waldron H Rand Company, PC | 1 | 100% | 0% |
| 504 | Copenhagen Offshore Partners, Inc. | 1 | 100% | 0% |
| 504 | N-Side, LLC | 1 | 100% | 0% |
| 504 | Radiant Innovative, Inc. | 1 | 100% | 0% |
| 504 | Delsys, Inc. | 1 | 100% | 0% |
| 504 | Asimov, Inc. | 1 | 100% | 0% |
| 504 | Xsphera Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Breezeway Homes, Inc. | 1 | 100% | 0% |
| 504 | Northbay Solutions, LLC | 1 | 100% | 0% |
| 504 | Phoenix Tailings, Inc. | 1 | 100% | 0% |
| 504 | Evolved by Nature, Inc. | 1 | 100% | 0% |
| 504 | Monotype Imaging Holdings | 1 | 100% | 0% |
| 504 | Competition Dynamics, Inc. | 1 | 100% | 0% |
| 504 | G2 Collaborative | 1 | 100% | 0% |
| 504 | Khan Law, PLLC | 1 | 100% | 0% |
| 504 | William Rawn Associates Architects, Inc. | 1 | 100% | 0% |
| 504 | Boston Harbor Consulting, LLC | 1 | 100% | 0% |
| 504 | Cytiva US, LLC | 1 | 100% | 0% |
| 504 | RG Vanderweil Engineers, LLP | 1 | 100% | 0% |
| 504 | Camelot Energy Group, LLC | 1 | 100% | 0% |
| 504 | Adept in, Inc. | 1 | 100% | 0% |
| 504 | Openclinica, LLC | 1 | 100% | 0% |
| 504 | Tsoi/Kobus & Associates, Inc. | 1 | 100% | 0% |
| 504 | Biostatistical Consulting, Inc. | 1 | 100% | 0% |
| 504 | Alphasimplex Group, LLC | 1 | 100% | 0% |
| 504 | Design Distill, LLC | 1 | 100% | 0% |
| 504 | Geomali, Inc. | 1 | 100% | 0% |
| 504 | Atmospheric and Environmental Rese | 1 | 100% | 0% |
| 504 | Business Value Intelligence Services, Inc. | 1 | 100% | 0% |
| 504 | Lapix Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Nymbl, Inc. | 1 | 100% | 0% |
| 504 | 1910 Genetics, Inc. | 1 | 100% | 0% |
| 504 | EBP US, Inc. | 1 | 100% | 0% |
| 504 | Sanders, Walsh & Eaton Cpa’S, LLC | 1 | 100% | 0% |
| 504 | Healthbeacon US, Inc. | 1 | 100% | 0% |
| 504 | Treviicos Corporation | 1 | 0% | 100% |
| 504 | Maidstone Consulting Group, LLC | 1 | 100% | 0% |
| 504 | Entact Bio, Inc. | 1 | 100% | 0% |
| 504 | Simon Akkary CPA, LLC | 1 | 100% | 0% |
| 504 | Vassar Labs, Inc. | 1 | 100% | 0% |
| 504 | Clymb Clinical, LLC | 1 | 100% | 0% |
| 504 | Mimecast North America, Inc. | 1 | 100% | 0% |
| 504 | Prodct, LLC | 1 | 100% | 0% |
| 504 | Stax, LLC | 1 | 100% | 0% |
| 504 | Anokiwave, Inc. | 1 | 100% | 0% |
| 504 | Jenike & Johanson, Inc. | 1 | 100% | 0% |
| 504 | CQV Associates, Inc. | 1 | 100% | 0% |
| 504 | Neon Technician Systems, Inc. | 1 | 100% | 0% |
| 504 | Osmoses, Inc. | 1 | 100% | 0% |
| 504 | Shah Dixit and Associates, P C | 1 | 100% | 0% |
| 504 | Empirix, Inc. | 1 | 100% | 0% |
| 504 | Iadvize, Inc. | 1 | 100% | 0% |
| 504 | Tuvoli, LLC | 1 | 100% | 0% |
| 504 | Blockcarbon, Inc. | 1 | 100% | 0% |
| 504 | Cimcon Software, LLC | 1 | 100% | 0% |
| 504 | Mercy Bioanalytics, Inc. | 1 | 100% | 0% |
| 504 | Ip Technology, LLC | 1 | 100% | 0% |
| 504 | MRCC Techforza, Corp. | 1 | 100% | 0% |
| 504 | Consolut International, LLC | 1 | 100% | 0% |
| 504 | Quanterix Corporation | 1 | 100% | 0% |
| 504 | Garuda Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Kronos Bio, Inc. | 1 | 100% | 0% |
| 504 | Nextera Robotic Systems, Inc. | 1 | 100% | 0% |
| 504 | Drummey Rosane Anderson, Inc. | 1 | 100% | 0% |
| 504 | Thrive Operations, LLC | 1 | 100% | 0% |
| 504 | Capital Accounting Solutions, Corp. | 1 | 100% | 0% |
| 504 | Lithios, Inc. | 1 | 100% | 0% |
| 504 | Advocates for Human Potential, Inc. | 1 | 100% | 0% |
| 504 | Kano Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | West Stone Consulting, LLC | 1 | 100% | 0% |
| 504 | Bodyshopbids, Inc. | 1 | 100% | 0% |
| 504 | Cubic, Inc. | 1 | 100% | 0% |
| 504 | Didge NX, Inc. | 1 | 100% | 0% |
| 504 | Avant-Garde Health, Inc. | 1 | 100% | 0% |
| 504 | Caliper Corporation | 1 | 100% | 0% |
| 504 | Learnable, Inc. | 1 | 100% | 0% |
| 504 | Edge Environment Sustainability Consulting, Inc. | 1 | 100% | 0% |
| 504 | Scholar Rock Subsidiary of School, Inc. | 1 | 100% | 0% |
| 504 | Hemanext, Inc. | 1 | 100% | 0% |
| 504 | Tripyramid Structures, Inc. | 1 | 100% | 0% |
| 504 | Bfly Operations, Inc. | 1 | 100% | 0% |
| 504 | Cellmosaic, Inc. | 1 | 100% | 0% |
| 504 | Institute for Protein Innovation, Inc. | 1 | 100% | 0% |
| 504 | Safety-Kleen Systems, Inc. | 1 | 100% | 0% |
| 504 | Tomorrownow ORG, Inc. | 1 | 100% | 0% |
| 504 | Batavia Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Cartesian Systems, Inc. | 1 | 100% | 0% |
| 504 | Palleon Pharmaceuticals, Inc. | 1 | 100% | 0% |
| 504 | Metware Biotechnology, Inc. | 1 | 100% | 0% |
| 504 | Flagship Labs 84, Inc. | 1 | 100% | 0% |
| 504 | Anagenex, Inc. | 1 | 100% | 0% |
| 504 | Walden Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Mythic Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Quotient Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Braun Weiss, Inc. | 1 | 100% | 0% |
| 504 | Day Zero Diagnostics, Inc. | 1 | 100% | 0% |
| 504 | Norbella, Inc. | 1 | 100% | 0% |
| 504 | Evolv Technologies, Inc. | 1 | 0% | 100% |
| 504 | Solid Biosciences, Inc. | 1 | 100% | 0% |
| 504 | Intelycare, Inc. | 1 | 100% | 0% |
| 504 | Moma Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | Compass Therapeutics Advisors, Inc. | 1 | 100% | 0% |
| 504 | Suspect Technologies, Inc. | 1 | 100% | 0% |
| 504 | Fusion Construction and Masonry | 1 | 0% | 100% |
| 504 | Arbor Biotechnologies, Inc. | 1 | 100% | 0% |
| 504 | KGS Buildings, Inc. | 1 | 100% | 0% |
| 504 | Whitehead Institute of Biomedical Research | 1 | 100% | 0% |
| 504 | New England Controls, Inc. | 1 | 100% | 0% |
| 504 | Dispatch Technologies, Inc. | 1 | 100% | 0% |
| 504 | The Predictive Index, LLC | 1 | 100% | 0% |
| 504 | Greatpointhr, Inc. | 1 | 100% | 0% |
| 504 | Axyomcore, Inc. | 1 | 100% | 0% |
| 504 | Lifecanvas Technologies, Inc. | 1 | 100% | 0% |
| 504 | Acousticabio, Inc. | 1 | 100% | 0% |
| 504 | Secure Code Warrior, Inc. | 1 | 100% | 0% |
| 504 | Elicio Therapeutics, Inc. | 1 | 100% | 0% |
| 504 | HL Acquisition, Inc. | 1 | 100% | 0% |
| 504 | Alltrna, Inc. | 1 | 100% | 0% |
| 504 | Mayer Hoffman Mccann, PC | 1 | 100% | 0% |
| 504 | Phenomic Bio, Inc. | 1 | 100% | 0% |
